Atish Patel

2.6k total citations · 1 hit paper
33 papers, 2.0k citations indexed

About

Atish Patel is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Atish Patel has authored 33 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 15 papers in Molecular Biology and 9 papers in Surgery. Recurrent topics in Atish Patel's work include Drug Transport and Resistance Mechanisms (26 papers), Cancer therapeutics and mechanisms (10 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers). Atish Patel is often cited by papers focused on Drug Transport and Resistance Mechanisms (26 papers), Cancer therapeutics and mechanisms (10 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers). Atish Patel collaborates with scholars based in United States, China and Malaysia. Atish Patel's co-authors include Zhe‐Sheng Chen, Liuya Wei, Huizhong Xu, Guofang Chen, Rishil J. Kathawala, Kamlesh Sodani, Nagaraju Anreddy, Tanaji T. Talele, Liwu Fu and Suresh V. Ambudkar and has published in prestigious journals such as PLoS ONE, Cancer Research and British Journal of Pharmacology.

In The Last Decade

Atish Patel

32 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Silver nanoparticles: synthesis, properties, and therapeutic applications

2014 757 citations Liuya Wei, Huizhong Xu et al. Drug Discovery Today profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Atish Patel United States	22	866	740	533	334	198	33	2.0k
Hiroshi Arakawa Japan	24	459 0.5×	431 0.6×	384 0.7×	271 0.8×	146 0.7×	115	2.2k
Donato Colangelo Italy	28	741 0.9×	696 0.9×	181 0.3×	325 1.0×	64 0.3×	74	2.0k
Ana Cristina Gonçalves Portugal	27	588 0.7×	1.2k 1.7×	167 0.3×	279 0.8×	48 0.2×	132	2.7k
Wang Ma China	24	487 0.6×	1.8k 2.4×	383 0.7×	489 1.5×	63 0.3×	75	3.2k
Hamidreza Montazeri Aliabadi United States	24	302 0.3×	1.1k 1.5×	145 0.3×	285 0.9×	96 0.5×	64	2.4k
Chunyan Gao China	27	373 0.4×	586 0.8×	337 0.6×	76 0.2×	45 0.2×	117	2.0k
Qin Lu China	32	399 0.5×	1.2k 1.6×	246 0.5×	875 2.6×	43 0.2×	106	3.0k
Marco Cordani Spain	26	486 0.6×	1.1k 1.5×	709 1.3×	668 2.0×	27 0.1×	72	3.0k
Barbara J.S. Sanderson Australia	24	229 0.3×	1.1k 1.5×	549 1.0×	192 0.6×	45 0.2×	48	2.3k
Mariusz Kaczmarek Poland	23	401 0.5×	730 1.0×	319 0.6×	287 0.9×	43 0.2×	119	2.1k

Countries citing papers authored by Atish Patel

Since Specialization

Citations

This map shows the geographic impact of Atish Patel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atish Patel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atish Patel more than expected).

Fields of papers citing papers by Atish Patel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atish Patel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atish Patel. The network helps show where Atish Patel may publish in the future.

Co-authorship network of co-authors of Atish Patel

This figure shows the co-authorship network connecting the top 25 collaborators of Atish Patel. A scholar is included among the top collaborators of Atish Patel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atish Patel. Atish Patel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Patel, Atish, et al.. (2025). Effects of dopamine agonists on the estradiol-induced prolactin surge in ovariectomized female Wistar Han rats. Toxicological Sciences. 205(1). 65–73.

Patel, Atish, Tianwen Li, Nagaraju Anreddy, et al.. (2017). Suppression of ABCG2 mediated MDR in vitro and in vivo by a novel inhibitor of ABCG2 drug transport. Pharmacological Research. 121. 184–193. 15 indexed citations

Zhang, Hui, Atish Patel, Rishil J. Kathawala, et al.. (2017). The BTK Inhibitor Ibrutinib (PCI-32765) Overcomes Paclitaxel Resistance in ABCB1- and ABCC10-Overexpressing Cells and Tumors. Molecular Cancer Therapeutics. 16(6). 1021–1030. 31 indexed citations

Katayama, Kazuhiro, Khyati Kapoor, Shinobu Ohnuma, et al.. (2015). Revealing the fate of cell surface human P-glycoprotein (ABCB1): The lysosomal degradation pathway. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1853(10). 2361–2370. 31 indexed citations

Anreddy, Nagaraju, Pranav Gupta, Rishil J. Kathawala, et al.. (2014). Tyrosine Kinase Inhibitors as Reversal Agents for ABC Transporter Mediated Drug Resistance. Molecules. 19(9). 13848–13877. 90 indexed citations

Wang, Yi‐Jun, Rishil J. Kathawala, Yunkai Zhang, et al.. (2014). Motesanib (AMG706), a potent multikinase inhibitor, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCB1. Biochemical Pharmacology. 90(4). 367–378. 48 indexed citations

Kathawala, Rishil J., Kamlesh Sodani, Kang Chen, et al.. (2014). Masitinib Antagonizes ATP-Binding Cassette Subfamily C Member 10–Mediated Paclitaxel Resistance: A Preclinical Study. Molecular Cancer Therapeutics. 13(3). 714–723. 34 indexed citations

Zhang, Hui, Atish Patel, Shaolin Ma, et al.. (2014). In vitro, in vivo and ex vivo characterization of ibrutinib: a potent inhibitor of the efflux function of the transporter MRP1. British Journal of Pharmacology. 171(24). 5845–5857. 45 indexed citations

Zhang, Hui, De‐Shen Wang, Rishil J. Kathawala, et al.. (2014). AST1306, a potent EGFR inhibitor, antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance. Cancer Letters. 350(1-2). 61–68. 29 indexed citations

10.

Sodani, Kamlesh, Atish Patel, Nagaraju Anreddy, et al.. (2014). Telatinib reverses chemotherapeutic multidrug resistance mediated by ABCG2 efflux transporter in vitro and in vivo. Biochemical Pharmacology. 89(1). 52–61. 41 indexed citations

11.

Wei, Liuya, et al.. (2014). Silver nanoparticles: synthesis, properties, and therapeutic applications. Drug Discovery Today. 20(5). 595–601. 757 indexed citations breakdown →

12.

Kathawala, Rishil J., Jun-Jiang Chen, Yunkai Zhang, et al.. (2014). Masitinib antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance. International Journal of Oncology. 44(5). 1634–1642. 26 indexed citations

13.

Anreddy, Nagaraju, Atish Patel, Kamlesh Sodani, et al.. (2014). PD173074, a selective FGFR inhibitor, reverses MRP7 (ABCC10)-mediated MDR. Acta Pharmaceutica Sinica B. 4(3). 202–207. 26 indexed citations

14.

Wang, De‐Shen, Atish Patel, Hong‐May Sim, et al.. (2014). ARRY‐334543 Reverses Multidrug Resistance by Antagonizing the Activity of ATP‐Binding Cassette Subfamily G Member 2. Journal of Cellular Biochemistry. 115(8). 1381–1391. 17 indexed citations

15.

Patel, Atish, Amit K. Tiwari, Eduardo E. Chufán, et al.. (2013). PD173074, a selective FGFR inhibitor, reverses ABCB1-mediated drug resistance in cancer cells. Cancer Chemotherapy and Pharmacology. 72(1). 189–199. 41 indexed citations

16.

Chen, Jun-Jiang, Atish Patel, Kamlesh Sodani, et al.. (2013). BBA, a Synthetic Derivative of 23-hydroxybutulinic Acid, Reverses Multidrug Resistance by Inhibiting the Efflux Activity of MRP7 (ABCC10). PLoS ONE. 8(9). e74573–e74573. 15 indexed citations

17.

Sodani, Kamlesh, Amit K. Tiwari, Satyakam Singh, et al.. (2012). GW583340 and GW2974, human EGFR and HER-2 inhibitors, reverse ABCG2- and ABCB1-mediated drug resistance. Biochemical Pharmacology. 83(12). 1613–1622. 53 indexed citations

18.

Kuang, Yehong, Jay Pravin Patel, Kamlesh Sodani, et al.. (2012). OSI-930 analogues as novel reversal agents for ABCG2-mediated multidrug resistance. Biochemical Pharmacology. 84(6). 766–774. 18 indexed citations

19.

Sodani, Kamlesh, Atish Patel, Rishil J. Kathawala, & Zhe‐Sheng Chen. (2011). Multidrug resistance associated proteins in multidrug resistance. Chinese Journal of Cancer. 31(2). 58–72. 239 indexed citations

20.

Shi, Zhi, Amit K. Tiwari, Atish Patel, Liwu Fu, & Zhe‐Sheng Chen. (2011). Roles of Sildenafil in Enhancing Drug Sensitivity in Cancer. Cancer Research. 71(11). 3735–3738. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact